Showing results (1311-1320 of 1,407) with videos related to

Sort By:
Pageof 141
Pharmacology Research & Perspectives|June 13, 2017
Physiologically based pharmacokinetic modeling of tea catechin mixture in rats and humansFrancis C P Law, Meicun Yao, Hui-Chang Bi, et al.
Pharmacology Research & Perspectives|June 13, 2017
Analgesic and anti-inflammatory properties of novel, selective, and potent EP4 receptor antagonistsSrinivasan Chandrasekhar, Xiao-Peng Yu, Anita K Harvey, et al.
Pharmacology Research & Perspectives|June 13, 2017
Make up a missed lesson-New policy to ensure the interchangeability of generic drugs in ChinaBaobin Huang, Sarah L Barber, Mingzhe Xu, et al.
Pharmacology Research & Perspectives|July 12, 2018
Enantioselective pharmacokinetics of tramadol and its three main metabolites; impact of CYP2D6, CYP2B6, and CYP3A4 genotypePernilla Haage, Robert Kronstrand, Martin Josefsson, et al.
Pharmacology Research & Perspectives|April 4, 2018
Revisiting the putative role of heme as a trigger of inflammationFlorence Vallelian, Christian A Schaer, Jeremy W Deuel, et al.
Pharmacology Research & Perspectives|June 26, 2018
The G protein-coupled estrogen receptor agonist, G-1, attenuates BK channel activation in cerebral arterial smooth muscle cellsKirk W Evanson, Jacob A Goldsmith, Payal Ghosh, et al.
Pharmacology Research & Perspectives|February 19, 2015
Cariprazine exerts antimanic properties and interferes with dopamine D2 receptor β-arrestin interactionsYonglin Gao, Sean Peterson, Bernard Masri, et al.
Pharmacology Research & Perspectives|February 19, 2015
Genetic variation in aryl N-acetyltransferase results in significant differences in the pharmacokinetic and safety profiles of amifampridine (3,4-diaminopyridine) phosphatePeter E Haroldsen, Marvin R Garovoy, Donald G Musson, et al.
Pharmacology Research & Perspectives|February 19, 2015
Active surveillance of visual impairment due to adverse drug reactions: findings from a national study in the United KingdomPhillippa M Cumberland, Isabelle Russell-Eggitt, Jugnoo S Rahi
Pharmacology Research & Perspectives|March 3, 2015
A single-dose mass balance and metabolite-profiling study of vemurafenib in patients with metastatic melanomaSimone M Goldinger, Jeannine Rinderknecht, Reinhard Dummer, et al.
Pageof 141